Gregory C. Ireton, PhD
Scientist I
Greg Ireton is a native of the Northwest and obtained his BSc in Microbiology (Hons) from the University of Washington in 1994. After graduation, Greg worked as a research technician (1994-1999) in the Department of Microbiology, focusing on the biochemical and kinetic properties of human topoisomerase I with the anti-tumor drug camptothecin. Greg entered graduate studies in the Molecular and Cellular Biology Program at the University of Washington in 1999, studying protein x-ray crystallography and protein design in the laboratory of Barry Stoddard at the Fred Hutchinson Cancer Research Center. Greg collaborated with scientists at Washington State University working on enzymes for novel cancer therapies and completed his thesis,"Structural studies of yeast and bacterial cytosine deaminases: directed evolution and implications for anti-cancer gene therapy" in September of 2003.
Greg joined IDRI's Process Science Group as an Associate Scientist/Biochemist in 2003. Greg is currently working on projects related to the biochemical characterization and development of IDRI's next generation vaccine for leishmaniasis. Greg is also focused on leprosy antigen discovery, using bioinformatics to aid in the selection and design of new candidate antigens for the development of improved rapid diagnostic tests for leprosy.
- Steven G. Reed, PhD - Head of Research & Development, IDRI Founder
- Curtis D. Malloy, JD, MPH - President
- Jill Ashman, MSc - Senior Clinical Research Manager
- Susan Baldwin, PhD - Senior Scientist
- Anna Marie Beckmann, PhD - Vice President, Development & Regulatory
- Sylvie Bertholet, PhD - Senior Scientist
- Ajay Bhatia, PhD - Senior Scientist/PI
- Mark Brannon, PhD - Scientist II
- Darrick Carter, PhD - Director, Formulations
- Allen Casey - Group Leader, High Throughput Screening/Robotics
- James Chesko, PhD - Senior Scientist
- Jessica Cohen, JD - Associate General Counsel
- Rhea N. Coler, PhD - Vice President, Preclinical Biology
- Karen D. Cowgill, PhD, MSc - Clinical Research Manager
- Malcolm S. Duthie, PhD - Scientist II
- Stephanie Florio, PhD - Senior Scientist
- Christopher Fox, PhD - Scientist I/Lead Formulation Engineer
- Randall F Howard, PhD - Project Manager
- Gregory C. Ireton, PhD - Scientist I
- Edward A. Kesicki, PhD - Director, Small-Molecule Drug Discovery
- Karen Kinch - Vice President, Administration
- Jennifer Martino - Administrative Operations Manager
- Magdalini Moutaftsi, PhD - Scientist I
- Joshua Oluoch Odingo, PhD - Director, Chemistry
- Tanya Parish, PhD - Director, Drug Discovery
- Franco M. Piazza, MD, MPH - Medical Director
- Vanitha S. Raman, PhD - Scientist I
- David Roberts, PhD - Scientist II
- Angela Gollnick Schroeder, MBA - Project Manager
- Paul Sleath, PhD - Consultant, Manufacturing
- Robrick Smith - IT Manager
- Tara Smith - Controller
- Thomas Vedvick, PhD - Director, Process Sciences
- Winston Wicomb, PhD, LATG - Senior Scientist / Animal Facility Manager
- Julie Youssef - Human Resources Manager